Activated protein C resistance and anticardiolipin antibodies in patients with venous leg ulcers
Open Access
- 1 September 1997
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 37 (3) , 409-413
- https://doi.org/10.1016/s0190-9622(97)70141-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Activated Protein C Resistance and ThrombosisMayo Clinic Proceedings, 1996
- Coagulation factor V gene mutation associated with activated protein C resistance leading to recurrent thrombosis, leg ulcers, and lymphedema: successful treatment with intermittent compressionJournal of the American Academy of Dermatology, 1996
- Resistance to activated protein C: a common anticoagulant deficiency in patients with venous leg ulcerationBritish Journal of Dermatology, 1996
- Fibrinolytic abnormalities in two different cutaneousmanifestations of venous diseaseJournal of the American Academy of Dermatology, 1996
- Leg ulcersCurrent Problems in Dermatology, 1995
- Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.Journal of Clinical Investigation, 1994
- Anticardiolipin antibodies and ulcerations of the legJournal of the American Academy of Dermatology, 1994
- Activated protein C resistance caused by Arg506Gln mutation in factor VaThe Lancet, 1994
- Resistance to Activated Protein C as a Basis for Venous ThrombosisNew England Journal of Medicine, 1994
- Antiphospholipid SyndromeJournal of Investigative Dermatology, 1993